Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000679	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-12-28	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2022-01-27	view
JYSB2100089	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-04-01	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2021-05-09	view
JYSB2100090	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-04-01	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2021-03-31	view
JYSB2000613	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-12-10	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2021-02-02	view
JYSB2000342	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-07-08	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-09-17	view
JYSB1900231	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-09-04	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-08-18	view
JYSB2000350	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-06-30	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2020-07-01	view
JYSB2000334	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-06-28	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2020-07-01	view
JYSB2000192	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-05-23	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2020-05-22	view
JYSB2000149	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-05-09	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2020-05-08	view
JYSB2000030	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2020-02-19	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-04-23	view
JYSB1900115	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-06-03	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-02-27	view
JYSB1900127	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2019-06-24	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-02-26	view
JYSB1900332	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2019-11-29	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2019-12-10	view
JYSB1900121	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-05-31	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2019-06-11	view
JYSB1900061	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2019-03-11	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2019-05-17	view
JYSB1800200	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2018-09-29	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2019-05-06	view
JYSB1800138	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2018-07-09	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2019-02-22	view
JYSB1700012	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products	Supplementary Application	2017-02-17	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2018-12-04	view
JYSB1800120	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2018-06-04	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2018-07-26	view